Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jan;87(2):623-7.
doi: 10.1073/pnas.87.2.623.

Specific inhibition of long-lasting, L-type calcium channels by synthetic parathyroid hormone

Affiliations

Specific inhibition of long-lasting, L-type calcium channels by synthetic parathyroid hormone

P K Pang et al. Proc Natl Acad Sci U S A. 1990 Jan.

Abstract

The effect of an active synthetic N-terminal fragment of bovine parathyroid hormone (bPTH), bPTH-(1-34), on Ca2+ channels was studied in mouse neuroblastoma cells (N1E-115). With the whole-cell variation of the patch-clamp technique, T (transient) and L (long-lasting) types of Ca2+ currents were identified. Pharmacological characterization showed that the L current was amplified by the Ca2+ channel stimulator BAY K-8644, but the T current was unaffected. The administration of bPTH-(1-34) produced dose-related inhibition of the L current, which could be reversed by BAY K-8644. The peptide had no effect on the T current. In addition, use of the fluorescent indicator fura-2 showed that bPTH-(1-34) inhibited the KCl-stimulated increase in intracellular free Ca2+ in neuroblastoma cells with L channels but not in cells with T channels. An inactivated (oxidized) preparation of bPTH-(1-34) failed to affect the L current. High-affinity binding of labeled PTH analog to these neuroblastoma cells was also demonstrated. In addition, bPTH-(1-34) inhibited the L current in cultured vascular smooth muscle cells from rat tail artery. These data indicate that, in some tissues, PTH can act as an endogenous blocker of Ca2+ entry.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Endocrinology. 1983 Jan;112(1):284-9 - PubMed
    1. J Pharmacol Exp Ther. 1981 Mar;216(3):567-71 - PubMed
    1. J Physiol. 1978 May;278:265-86 - PubMed
    1. J Physiol. 1976 Aug;260(1):21-35 - PubMed
    1. J Exp Med. 1978 Nov 1;148(5):1400-13 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources